GSK sets third interim dividend at 17p per share for Q3 2026
GSK declared a 17p per share interim dividend for Q3 2026, up 6.3%, according to Seeking Alpha. Payment is scheduled for January 7, 2027.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
GSK has announced a third interim dividend of 17 pence per ordinary share for the third quarter of 2026, according to Seeking Alpha. The payout is 6.3% above the 16 pence paid in the same quarter of 2025 and matches the level of earlier quarters this year. With this installment, the total dividend the company expects to pay for 2026 reaches 70 pence per share.
At the October 27, 2026 exchange rate, the payment equals about $0.4524 per American Depositary Share, with each ADR representing two ordinary shares. The money is due on January 7, 2027. Eligibility is set by a record date of November 13, 2026; ordinary shares trade without the entitlement from November 12, while ADRs do so from November 13. Holders of ordinary shares who want to join the dividend reinvestment plan must file elections by December 14, 2026.
why it matters
A steady, slightly larger payout signals predictable cash returns to shareholders, which matters most for income-focused holders of GSK shares and ADRs. The dollar value of each ADR depends on the exchange rate and the number of shares it represents.
tags
instruments
sources
- GSK declares $0.4524/ADS or 17p/share dividend — Seeking Alpha, 28 October 2026 at 08:27 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗